UNSPSC 51282004: Chloramphenicol or chloramphenicolum

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C11H12Cl2N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66974FR9Q1, chemically known as dl-threo-2,2-dichloro-n-(beta-hydroxy-alpha-hydroxymethyl-4-nitrophenethyl)acetamide but generally known as chloramphenicol, which bears US NIH Compound Identifier 298. European Medicines Agency schedules Chloramphenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06173MIG.

UNSPSC 51282004 Chloramphenicol or chloramphenicolum is a Commodity code covering specific pharmaceutical active ingredients and their formulations. State and local governments procure chloramphenicol—an antibiotic used in ophthalmic, otic, and systemic applications—through cooperative purchasing agreements that bundle it with broader generic pharmaceutical portfolios. The buying entities are state agencies, counties, municipalities, and special-purpose district healthcare systems that source medications through established wholesale distribution networks rather than direct manufacturer relationships. Procurement occurs via RFP and cooperative purchasing vehicles designed to lock in competitive pricing across multiple jurisdictions while ensuring FDA compliance, cGMP certification, and Drug Supply Chain Security Act adherence.

The most visible recent activity centers on the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, which issued an RFP (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities in Minnesota and Oregon. The procurement structure requires vendors to maintain relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and submit detailed product data including NDC codes, SKUs, and manufacturing locations by the March 26, 2026 response deadline. The RFP weights price competitiveness at 75 percent, compliance with administrative data formats at 5 percent, EDI capability at 5 percent, fixed pricing at 10 percent, and acceptance of a 3 percent administrative fee at 5 percent. Awarded contracts run two years for new vendors with optional extensions, or through June 30, 2028 for incumbents, with products required to reach the marketplace by May 15, 2026 and agreements effective July 1, 2026.